Investigator
Michael Ryan Corces
J. DAVID GLADSTONE INSTITUTES · funded by NIA
- Companies
- 2
- Grants
- 2
- Non-dilutive funding
- $1.7M
- First award
- Aug 15, 2021
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Feb 15, 2026.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- J. DAVID GLADSTONE INSTITUTESMomentum in another area
NeuroGrant-only
- J. DAVID GLADSTONE INSTITUTESMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Genetic dissection of the 17q21.31 MAPT locus in neurodegenerative disease
$790kFeb 15, 2026NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11276353 (opens the source filing in a new tab)
- P01
Project 4: Cross-species Dissection of Cellular Response to APOE Genotype and AD Pathology Using Single-cell Multi-omics
$929kAug 15, 2021NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11166579 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources